Effects Of SenQiShan On Fat Metabolism In Patients With Type 2 Diabetes Mellitus

ObjectiveInsulin resistance has been recognized as one of the pathogenesis in type 2 diabetes, And with the improvement of living standards, Insulin resistance in the pathogenesis of type 2 diabetes is becoming increasingly important. A large number of clinical and basic research evidence to show that Obesity is an important factor leading to insulin resistance, The obese patients compared with normal subjects have a higher level of fat oxidation, So that the non-esterified free fatty acid levels. Hyperlipidemia high serum free fatty acids are considered to cause insulin resistance in obesity, an important factor.Chinese medical literature there is no insulin resistance and hyperlipidemia in the name of disease and its complications, However, the discussion has related. Most of the literature suggests that the generation of hyperlipidemia and liver, spleen and kidney three dirty most closely, the spleen is especially to be. Its pathogenesis is based on deficiency in the organs of the decline, food feigan, good sit quiet, impassioned injured workers, aging, and so on, formation of virtual evil evidence, The order is empty oriented, phlegm stasis. Labeled spleen health movement dereliction of duty, or liver deficiency Shuxie weakness, or inability to kidney gasification, resulting in blood stasis real evil generation, pulse Road congestion caused by blood stasis. Thus, qi stagnation and hyperlipidemia on insulin resistance is closely related to clinical.ObjectivesTo investigate the effect of SenQiShan onFat metabolism in patients with Type 2 diabetes mellitus.Methods A prospective and casecontorl study was conducted.120 patients with Type 2 diabetes mellitus were divided into SenQiShan group(n=72) and Fenofibrate Dispersible Tablets group(n=76), these patients were followed up for 8 weeks. Blood glucose, TG and HbAlc were measured by using an biochemical analysis.ResultSenQiShan group glucose levels after treatment, BMI group than the fenofibrate significantly decreased (p≤0.05), TG to reduce the level of no difference.ConclusionSenQiShan group can effectively reduce the TG and glucose levels, At the same time can be reduced to some extent, the body mass index in obese patients.